The kinetics of apolipoprotein (apo) B-100 in particles containing apo E (B,E particles) or lacking apo E (B particles) were studied in Watanabe heritable hyperlipidemic (WHHL) rabbits deficient in low density lipoprotein (LDL) receptors, and compared with those of normal rabbits after injection of radioiodinated very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), and LDL. In both groups results of kinetic modeling were consistent with the hypothesis that all apo B enters the plasma in VLDL, mainly as BE particles, followed by delipidation and partial conversion to IDL and LDL, with concomitant conversion of some B,E particles to B particles. In WHHL rabbits, production of VLDL apo B was reduced by 40%, but LDL production was increased threefold. Defective removal of BE and B particles in all three lipoprotein classes, coupled with preserved processes of delipidation, can account for the observed increases in the concentration of apo B (threefold in VLDL, fivefold in IDL, and twenty-twofold in LDL) in WHHL rabbits.
Introduction
The discovery of a mutant rabbit model of human familial hypercholesterolemia, in which low density lipoprotein (LDL) receptors are grossly deficient (the Watanabe heritable hyperlipidemic [WHHL]' rabbit), has increased the usefulness of this species for the study oflipoprotein metabolism. In these animals, the concentration of very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) as well as that of LDL is increased (1) . Metabolic studies in WHHL rabbits have shown that the rate of irreversible disposal of VLDL (2) as well as that ofLDL (3, 4) is impaired, whereas that ofchylomicrons is normal (5) . As in normal rabbits virtually all apolipoprotein (apo) B-100 has been shown to appear in liver perfusates of WHHL rabbits as VLDL, and the rate of accumulation of apo B is not increased in these perfusates (6) . These observations, together with the finding that the fraction of VLDL converted to LDL is increased in WHHL rabbits (2) , have led to several important conclusions: (a) chylomicron remnants are taken up into the liver by a receptor genetically distinct from the LDL receptor;
1. Abbreviations used in thispaper: apo, apolipoprotein; IDL, intermediate density lipoproteins; NZW, New Zealand White (rabbits); WHHL, Watanabe heritable hyperlipidemic (rabbits).
(b) receptor deficiency increases LDL levels by increasing LDL formation as well as by reducing its catabolism; (c) the increased formation of LDL associated with receptor deficiency is not explained by increased secretion of VLDL or de novo secretion of lipoproteins of higher density, but rather by an increased fractional conversion of VLDL to LDL; and (d) the LDL receptor is normally responsible for the direct uptake of VLDL remnants. These conclusions are of particular interest because the rabbit resembles the human with respect to some fundamental characteristics of lipoprotein metabolism, including the secretion of a single species ofapo B (B-100) by the liver (6) and the presence of an active mechanism for transfer of cholesteryl esters and triglycerides among lipoprotein particles (7) (8) (9) .
The conclusions that have been reached about the effect of LDL receptor deficiency on the metabolism oflipoproteins containing apo B-I00 in rabbits have remained qualitative because methods to deal with the structural and metabolic heterogeneity oflipoproteins in this species have not been developed. We have recently reported the application of a new kinetic approach to the analysis of lipoprotein heterogeneity and its use to quantify the rate of secretion of apo B-100 and its subsequent metabolic fate in normal New Zealand White (NZW) rabbits (10) . Our data indicate that all the major lipoprotein classes that contain apo B-100 are heterogeneous with respect to content of apo E, and include particles that contain apo E (B,E particles) as well as particles that lack apo E (B particles). The presence of apo E in VLDL particles was shown to have a major influence on the rate of irreversible disposal of component apo B and its conversion to lipoproteins of higher density, IDL and LDL.
The evident influence of apo E upon lipoprotein metabolism in rabbits is of particular interest because this protein, like apo B-100, is a ligand for the LDL receptor (1 1, 12) . The lack of LDL receptors should therefore influence the metabolism of B,E particles as well as that of B particles.
We have carried out experiments in WHHL homozygotes, comparable with those that we have reported for NZW rabbits, to test various hypotheses concerning the influence of LDL receptor deficiency upon the metabolism oflipoproteins containing apo E as well as apo B-100 and to quantify the effect of receptor deficiency on rates of lipoprotein interconversions and irreversible disposal. Our results confirm previous qualitative conclusions, yield quantitative estimates ofthe secretion of VLDL particles and their conversion to IDL and LDL, and provide fresh insights into the nature of the kinetic heterogeneity seen in all classes of lipoproteins containing apo B. In addition, our observations suggest that some VLDL particles are removed from the blood of WHHL rabbits by high affinity mechanisms.
All animals were fed lab rabbit chow (Ralston Purina Co., St. Louis, MO). Before and during in vivo experiments, the animals were kept in individual cages (10) . For liver perfusions, two WHHL rabbits (liver weights 95 and 110 g) and two NZW rabbits (liver weights 91 and 95 g) were used.
Preparation oflipoproteins. The preparation of lipoproteins for experiments on NZW rabbits has been described (10) . For experiments on WHHL rabbits, 10 ml of blood was withdrawn from an ear vein 4-5 d before in vivo experiments and mixed with disodium EDTA (1 mg/ml), sodium azide (0.2 mg/ml), and gentamycin (10 Mg/ml), pH 7.4. Lipoproteins were isolated from plasma by sequential ultracentrifugation at 45,000 rpm in a Beckman ultracentrifuge (50.2 rotor) at 12'C as follows: VLDL (d < 1.006 g/ml) for 16 h; IDL (1.006 < d < 1.109 g/ml) for 18 h; and LDL (1.019 < d < 1.063 g/ml) for 20 h. Lipoproteins used for iodination were recentrifuged at 39,000 rpm in a 40.3 rotor at 12'C for 20 h, then dialyzed against 0.15 M NaCl containing 0.01% disodium EDTA, 0.02% sodium azide, pH 7.4, and iodinated with 125I (Pharmacia Fine Chemicals, Uppsala, Sweden) or 1311 (ICN Biochemicals, Irvine, CA) by a modification ofthe method of McFarlane (13, 14) to a specific activity of 110-550 dpm/ng protein. Free iodine was removed on a column (1 X 10 cm) of Sephadex G-50 (Pharniacia Fine Chemicals). As determined by assay ofcomponents separated by sodium dodecyl sulfate gel electrophoresis, at least 90% of the apo El of VLDL was in apo B-100. The percentage oftotal radioiodine in apo B, measured as radioiodine insoluble in 50% isopropranol, was -51, 83, and 79% in VLDL, IDL, and LDL, respectively. The labeled lipoprotein (0.5-1 mg protein) was mixed with 1 ml ofautologous plasma and dialyzed twice against 4 liters of 0.15 M NaCl containing 0.01% disodium EDTA, 0.02% sodium azide, and gentamycin (5 sg/ml), pH 7.4, at 4°C. Before injection into animals, iodinated lipoproteins were dialyzed against 0.15 M NaCl for 1-2 h and passed through a 0.22-Mm filter (Gelman Sciences, Inc., Ann Arbor, MI).
VLDL were also separated from some samples of fresh plasma on a 2 X 90-cm column of 6% agarose (Biogel A-5 M; Bio-Rad Laboratories, Richmond, CA) (15) to compare their composioion with that of ultracentrifuged VLDL. 2 to 3 ml of plasma was applied to the column. Elution was at 10 ml/h with 0.15 M NaCl containing disodium EDTA (0.01%) and sodium azide (0.02%), pH was determined by subtracting radioactivity in apo B of the unbound fraction from that in original whole plasma. The concentration of apo B in VLDL, IDL, and LDL in each experimental animal was determined on pools ofplasma obtained between 3 min and 6 h after uptake of radioiodinated lipoproteins. The content of radioiqdine (derived from the injected 125I-or '311-apo B) in VLDL, IDL, and LDL separated by sequential ultracentrifugation was measured as described above. The specific activity ofapo B in these fractions (which had been recentrifuged to remove contaminating plasma proteins) was determined as described (10) . The concentration of apo B in each lipoprotein fraction was calculated by dividing the concentration of radioiodine in apo B by its specific activity (10) .
Lipid and protein analysis. Total cholesterol and triglyceride concentrations in plasma were measured by an automated technique (18) . Concentration ofapo E in plasma and lipoprotein fractions was measured by radioimmunoassay (1) .
Liverperfusion. [3Hflysine for 30-60 min in a recirculating system, then flushed with nonradioactive perfusate for 3-4 min (150 ml). Perfusate was then collected for 30 min in a non-recirculating system and finally for an additional 30 min in a recirculating system (6) . Samples ofsingle-pass perfusates were applied to the anti-E affinity column and content of 3H in B and B,E particles was determined by liquid scintillation spectrometry in aquasol (NEN Research Products, Boston, MA). Samples of recirculating perfusates were separated by density gradient ultracentrifugation, as described below.
Density gradient centrifugation. This procedure was modified from one described previously (19) . Three solutions ofincreasing density were layered into a Beckman centrifuge tube (1.3 X 6.4 cm): 2.0 ml of water, 2.1 ml of 0.64 M NaCl (d = 1.025 g/ml); and 2.1 ml of 1.28 M NaCl (4 = 1.050 g/ml). Densities ofliver perfusate samples were adjusted to 1.05 and 1.025 g/ml and used to form the lower two layers of the gradient. The sample was centrifuged in a Beckman SW 41 rotor at 39,000 rpm for 22 h at 120C. The top fraction (0.5 ml) was obtained by tube slicing and the tube wall was rinsed with 0.5 ml of water. Then, 11 fractions (0.5 ml/fraction) were obtained sequentially by aspiration at the meniscus with an automatic pipette (Pipetman; Gilson Medical Electronics, Inc., Middleton, WI). The density of each fraction was measured with a conductivity meter and content of radioiodine in apo B was determined as above.
Kinetic analysis. Content ofapo B in B,E and B particles was measured in whole plasma in six experiments each for VLDL, IDL, and LDL injections into WHHL rabbits. The averaged data were analyzed in a fashion similar to that already used in similar experiments on normal NZW rabbits (10) . Briefly, this analysis took the form offirst developing a model describing the kinetics ofplasma B,E and B particles after LDL injection. The same analysis was again performed for injections of IDL and VLDL. By initially assuming the LDL model to be known for analysis ofthe IDL model and the LDL and IDL models to be known for analysis of the VLDL model, good estimates of the parameters of the three subsystems of the combined model were possible using only whole plasma B,E and B particle data. In the final parameter fitting procedure all adjustable parameters were fitted to all the data at the same time, using the time interrupt feature of the SAAM 27 program (20, 21 Two additional constraints were imposed on the model previously published for normal rabbits (10) . The fractional rates of conversion of VLDL B,E and B particles to IDL B,E and B particles, respectively, were assumed equal. This hypothesis, which fit the data well, was not tested in our published model. The fractional rate of conversion of LDL B,E particles to B particles was poorly determined because of the low rate of transport of both mass and radioactivity along this pathway using the model configuration adopted here (10) . Since this pathway was well determined in the WHHL model, this parameter in the normal model was set equal to that in the WHHL model, a hypothesis that fitted the data well.
Of the 40 rate constants in both models, 27 were assumed dependent, leaving 13 adjustable parameters. These parameters were adjusted iteratively at the same time to the 18 sets of average tracer data (plasma B,E, B, and total apo B radioactivity from LDL, IDL, and VLDL injections in both normal and WHHL rabbits) using the SAAM 27 computer program. The fitting procedure was further constrained by assuming that all apo B production occurs in the VLDL density range. The IDL and LDL B,E and B masses in both normal and WHHL rabbits were weighted in the steady state solution and used to constrain the fitting of the tracer data. The statistical uncertainties of the adjustable parameters were estimated from the variance-covariance matrix at the least-squares fit.
Results
Lipoprotein-lipid and protein concentrations and distributions. In this and the following section, the data from not only WHHL rabbits but also NZW rabbits, some ofwhich have been reported previously (1, 10) , are compared. Concentrations of lipids, apo B, and apo E in plasma are shown in Table I . At the beginning and end of the experiments in WHHL rabbits, the mean plasma total cholesterol concentrations were 561 and 520 mg/dl, respectively; corresponding plasma triglyceride values were 415 and 378 mg/dl (n = 9). Plasma lipid values in 13 NZW rabbits have been reported elsewhere (10) . All (Table  II) , it can be estimated that the average number of apo E molecules in B,E particles for VLDL, IDL, and LDL, respectively, was 2.9, 1.4, and 0.44 in WHHL rabbits and 3.0, 1.1, and 1.4 in NZW rabbits. The low average number of apo E molecules in BE particles of LDL from WHHL rabbits may reflect ultracentrifugal dissociation of apo E. This possibility is supported by the observation that the E/B ratio in LDL obtained by gel permeation chromatography from WHHL rabbits was about twice that for ultracentrifuged LDL, as noted above. Evidently, the procedure of incubating the injected lipoproteins with autologous plasma led to reacquisition of the dissociated apo E. Similarly, the majority, but not all, ofapo B in newly secreted lipoproteins in perfusates of liver from NZW or WHHL rabbits was in B,E particles (Table IV) . Virtually no labeled apo B was tMean±SD (n = 6).
found in perfusate lipoprotein fractions with densities exceeding 1.005 g/ml in these experiments (Table V) . Lipoprotein kinetics. The kinetics of removal from whole plasma of radioiodine in total apo B injected as VLDL, IDL, and LDL are shown in Fig. 1 , together with the model-generated fits to the data for both NZW and WHHL rabbits. It is clear that the rates of disappearance of apo B from whole plasma of WHHL rabbits were considerably slower than those seen in NZW rabbits for all fractions injected. The rate of disappearance was greater after VLDL injection than after IDL and LDL injections in both groups. The fits of the model for NZW and WHHL rabbits to the data for B,E and B particles are shown in Figs. 2 and 3. The rates of disappearance of B,E particles from plasma were faster than those of B particles for all injections, but the magnitude of differences was greater in NZW rabbits.
The rate constants (h-'), transports (mg. dl-I h'), and calculated masses (mg. dlE') for NZW and WHHL rabbits are shown in Figs. 4 and 5. All rate constants were well determined with fractional standard deviations <0.10, with the exception of the two rate constants describing extravascular kinetics. These two constants had an average fractional standard deviation of 0.19.
The fractional rate ofirreversible loss ofVLDL B,E particles from plasma of WHHL rabbits was four times greater than that of VLDL B particles. However, this rate was only 10% of that for VLDL B,E particles in NZW rabbits. The fractional rates of loss of LDL B,E and B particles in WHHL rabbits were -10 and 15%, respectively, of those in NZW rabbits.
The total production rate of apo B in VLDL of WHHL rabbits was -60% of that in NZW rabbits (4.83 vs. 7.96 mg. dl' * h-). Conversely, the production rate of LDL apo B in WHHL rabbits exceeded that of NZW rabbits by almost a ilarity oflipoprotein metabolism in NZW and WHHL rabbitsessentially all apo B is secreted in particles with a density < 1.006 g/ml (i.e., VLDL). Previously, it was shown that virtually all newly synthesized apo B in liver perfusates from NZW and WHHL rabbits has a density < 1.010 g/ml (6). Our current findings, based upon density gradient ultracentrifugation of liver perfusates, indicate that < 2% of newly synthesized apo B is 
Discussion
We have shown that, as in normal (NZW) rabbits (10) Hours After Injection secreted in particles with densities exceeding 1.005 g/ml. The apo B ofliver perfusates, which was contained almost exclusively in VLDL, consisted mainly of B,E particles, but like VLDL isolated from blood plasma, an appreciable fraction (-30%) of B particles was also present. These perfusate particles were obtained during single-pass perfusions. However, additional experiments are required to determine the extent to which B,E and B particles are present in nascent VLDL within liver cells. Although the VLDL particles produced by the liver seem to be fundamentally comparable in NZW and WHHL rabbits, their rates of removal from the blood and conversion to particles of higher density differ greatly, presumably reflecting the virtual lack of functional LDL receptors in the latter. Our analysis suggests that the rate of secretion of apo B in WHHL rabbits is lower than in NZW rabbits, despite the grossly elevated levels of apo B in all lipoprotein fractions of WHHL rabbits. Furthermore, our model solutions suggest that most apo B enters plasma VLDL as B,E particles in both groups of animals, consistent with our independent observations of the properties of VLDL in liver perfusates, although the fraction of B particles in liver perfusates was somewhat higher than that predicted by the model. The overall fractional rate of irreversible disposal of IDL as well as LDL particles was only -15% ofthat observed in NZW rabbits, which suggests that 85% of these particles are normally removed by interaction with LDL receptors. This estimate exceeds the value of 70% that we (22) and others (3, 4) have observed from analysis of rates of disappearance of radioiodine (not exclusively apo B) from whole plasma after injection of labeled LDL or methyl LDL into normal or WHHL rabbits. This discrepancy reflects the fact that our estimate of the fractional catabolic rate of LDL in WHHL rabbits is similar to that observed by others (3, 4), but our estimate ofthis rate is somewhat higher for NZW rabbits.
Our initial hypothesis that the fractional rate of irreversible disposal of apo B in VLDL of WHHL rabbits would be similar to that of IDL and LDL was not consistent with the observation that the rate of removal from whole plasma of radioiodinated apo B injected as VLDL was substantially greater than that observed after injection of IDL or LDL. We therefore considered the possibility that B,E particles in VLDL, which we found to contain an average ofabout three molecules ofapo E, influenced the rate of irreversible disposal of VLDL B,E particles. This hypothesis was supported by the kinetic analysis of the whole plasma data. The fractional rate of irreversible disposal of B,E particles in VLDL ofWHHL rabbits was calculated to be fourfold that ofVLDL B particles, a ratio comparable with that observed in NZW rabbits.
The mechanism by which B,E particles in VLDL are removed more rapidly than B particles in WHHL rabbits is unclear. Additional experiments have shown that a small fraction of VLDL particles, whose diameter exceeds 450 A, is removed rapidly from the blood ofWHHL rabbits (unpublished data). VLDL of this size are also removed more rapidly from the blood of NZW rabbits, as we have observed previously in humans (23 (3, 4) no receptor-mediated clearance of LDL-protein has been detected in WHHL rabbits after ileal bypass (27) . In the bypassed animals, LDL-protein production was found to be reduced by 50% (27) Our observations confirm and extend those of Kita and associates (2), who first showed that the clearance of apo B of VLDL from whole plasma is delayed in WHHL rabbits and that it is converted to a greater extent to IDL and LDL. These observations have been interpreted to indicate that most VLDL apo B normally enters the liver as IDL, and that hepatic uptake of IDL apo B is selectively diminished in WHHL rabbits, so that a greater fraction is converted to LDL (29) . Our observations indicate that hepatic uptake of VLDL apo B as well as that of IDL apo B is reduced in WHHL rabbits, so that the increased formation ofLDL reflects reduced hepatic uptake ofits precursor at the stage of VLDL as well as IDL (Table VI) . The difference in conversion ofVLDL apo B to that of IDL is most pronounced for B,E particles, which presumably reflects the high affinity of particles that contain several molecules of apo E for the LDL receptor (30) (31) (32) . The data ofKita and associates have also been interpreted to indicate that IDL are normally taken up rapidly by the liver of normal rabbits (29 particles are converted B,E particles and found this hypothesis inconsistent with our data. This inconsistency can be appreciated in simpler terms by careful inspection of the tracer data. Ifboth B,E particle conversion to B and B particle conversion to B,E were to exist-i.e., equilibration-both sets of tracer data should have the same final slopes, a finding clearly inconsistent with our B,E and B particle data after injection of LDL, IDL, or VLDL. 2 We conclude that the method of analysis of apo B in whole plasma that we have employed in our kinetic experiments has two advantages as compared with the usual method of separating lipoprotein fractions from recipient animals for analysis. First, it avoids problems associated with incomplete separation of lipoprotein fractions by ultracentrifugation (10, 33) . Second, it permits straightforward analysis of heterogeneity related to the presence or absence of apo E in particles that contain apo B. Although B,E and B particles can be separated from lipoprotein fractions separated in the ultracentrifuge, such particles may have been modified by ultracentrifugal dissociation of apo E (34) (35) (36) .
Our method, however, continues to rely upon injection of lipoproteins that have been subjected to ultracentrifugal forces. We have attempted to minimize compositional alterations in the radioiodinated lipoproteins by incubating them with plasma of the recipient rabbits before injection. We have shown that the proportion of B,E and B particles in VLDL separated by gel chromatography and then radioiodinated is similar to that of ultracentrifuged VLDL, and we have found that the gel-filtered VLDL have similar kinetic properties to those of ultracentrifuged VLDL that have been incubated with autologous plasma (10) . We therefore conclude that whatever the extent of ultracentrifugal dissociation of apo E from rabbit VLDL particles, it does not irreversibly alter their metabolic behavior.
The methods that we have developed for analysis of apo B kinetics in rabbit blood plasma should be applicable to other species. Heterogeneity with respect to presence of apo E also exists in human lipoproteins that contain apo B (37-41). Therefore, our approach could yield new insights into human lipoprotein metabolism.
